Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07467213) titled 'Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction' on March 9.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Samsung Medical Center

Condition: Acute Myocardial Infarction (AMI) Gastrointestinal Bleeding

Intervention: Drug: Zastaprazan

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: April 1, 2026

Target Sample Size: 5000

To know more, visit https://clinic...